INSIGHTS ON CLINICAL TRIAL DESIGN

• Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies

  Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

• At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

  At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

• Rare Disease R&D: Continued Growth Amid Challenges

  The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.

• A Novel Digital Measure For Tracking Disease Progression In DMD

• The Perfect Solution For Recruitment, Retention, And ROI

  8/15/2024

  See how Citeline Connect was deployed to advance enrollment six months ahead of schedule for a sponsor’s Phase IV atopic dermatitis trial and build a community of engaged patients.

• Best Practices In Rare Disease Patient Recruitment

  3/9/2026

  Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

• FDA Guidance On Payment And Reimbursement To Research Subjects

  12/5/2025

  Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.

• Enhancing Decentralized Clinical Trials: The Power Of Direct To Patient Distribution

  7/5/2026

  How is direct-to-patient distribution reshaping decentralized clinical trials? Explore the models, strategies, and best practices driving a more patient-centric future for drug development.

• Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes

  5/22/2026

  Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.